This inventor holds 1 USPTO granted patent. Top assignee: Abbott Products Gmbh. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Lila Kallio Nee Pirkkala: Innovator in Therapeutic Chemistry
Introduction
Lila Kallio Nee Pirkkala is a notable inventor based in Kaarina, Finland. She has made significant contributions to the field of therapeutic chemistry, particularly in the development of compounds that target steroid hormone-dependent disorders. Her innovative work has led to the granting of a patent that showcases her expertise and dedication to improving health outcomes.
Latest Patents
Lila holds a patent for "Therapeutically active triazoles and their use," which focuses on Estratrien-triazoles corresponding to a specific formula. This invention is particularly useful in therapy for the treatment and prevention of steroid hormone-dependent disorders. It specifically addresses the inhibition of the 17β-hydroxysteroid dehydrogenase (17β-HSD) enzymes, which are crucial in managing various steroid hormone-related diseases.
Career Highlights
Lila Kallio has established herself as a prominent figure in her field through her innovative research and development efforts. Her work at Abbott Products GmbH has allowed her to collaborate with other experts and contribute to advancements in therapeutic solutions. Her dedication to her research has resulted in a patent that holds promise for future medical applications.
Collaborations
Lila has worked alongside esteemed colleagues such as Josef Messinger and Uwe Schoen. These collaborations have enriched her research and have been instrumental in the development of her patented innovations.
Conclusion
Lila Kallio Nee Pirkkala is a pioneering inventor whose work in therapeutic chemistry has the potential to significantly impact the treatment of steroid hormone-dependent disorders. Her contributions exemplify the importance of innovation in healthcare and the ongoing quest for effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile